Greg Lovins
Analyst · Robert W. Baird. Please go ahead
Thanks, Mitch. Hello everybody. I will provide some additional color on full-year results then I will walk you through our fourth quarter performance and our outlook for 2018. As Mitch said, 2017 represented another year of great progress towards our long-term financial targets. On slide seven of the supplemental presentation materials, we included our progress against our scorecard for the five-year goals ending in 2018. As you can see here, we are on track to meet or exceed these goals. We have delivered cumulative growth and adjusted EPS of 17% and significantly expanded return on capital, adjusting for the impact of U.S. Tax Reform in Q4. We believe our returns remain in the top quartile relative to our peers, a position we expect to maintain, while increasing our pace of investment for both organic growth and M&A. We continue to have ample capacity for these investments, while returning cash to shareholders in a disciplined manner. Our balance sheet remained strong but our net debt-to-EBITDA ratio on the low side of our targeted range at year end. In last March we introduce a new set of long-term targets, which carries through 2021. Now that we are only one year into this cycle, 2017 performance was on pace to deliver the new targets. Given the diversity of our end markets, our strong competitive advantages and our resilience as an organization to adjust course, we are confident in our ability to deliver to a wide range of business cycles. So let me now turn to more recent performance, our results for Q4. I will first address the transition to the new U.S. tax code, which had a negative impact on reported earnings in the fourth quarter, while improving our outlook going forward. We recorded a tax charge in Q4 of approximately $172 million or $1.91 per share, resulting in an effective tax rate for the quarter of 138% and 52% for the full year. This charge include the tax on deemed repatriation of accumulated untaxed foreign earnings, as well as the revaluation of deferred tax assets and liabilities, and this amount reflects our provisional estimate of the impact of the new legislation. We made to update this assessment over the coming months as new information becomes available, including interpretations of the legislation by various regulatory bodies. Our adjusted tax rate was 28%, which represents our estimate of where we would have ended the year in the absence of Tax Reform. This is consistent with the guidance we have provided in October and down from an approximately 32% for the same period last year. Looking forward, we anticipate that our 2018 tax rate will be in the mid-20s and we expect that rate to be sustainable. So focusing now on the underlying operating results for the quarter, our adjusted earnings per share was $1.33, up 34% compared to the prior year, which was above our expectations due to strong sales growth and margin expansion. We grew sales by 9.1% excluding currency, with 4.7% organic growth and 4.4% from acquisitions. Currency translation then added 2.8% to reported sales growth in the fourth quarter, within approximately $0.04 benefit to EPS compared to the same period last year. And our adjusted operating margin increased by 90 basis points to 10.3%, as the benefit from higher volume and productivity more than offset higher employee-related costs and the net impact of pricing and raw material costs. And productivity gains this quarter included approximately $16 million of net restructuring savings, most of which benefited the RBIS segment. And free cash was $166 million in the quarter and $422 million for the full year, up roughly $35 million compared to prior year, driven largely by our higher operating income. And in the quarter we repurchased approximately 200,000 shares as an aggregate cost to $25 million. For the full year, we repurchased 1.5 million shares at the cost of $130 million and we paid $156 million in dividends. And net of dilution our share count at year end declined modestly compared to 2016. So turning to the segment results for the quarter, Label and Graphic Materials sales were up 6% excluding currency, reflecting 1 point of benefit from the acquisition of Hanita. Organic sales growth of 5%, reflected continued strong growth of our high-value product lines, driven by specialty labels and graphics. Our Q4 growth also benefited by about a 0.5 point from some pre-buying by customers in advance of price increases announced for January. And breaking down LGM’s organic growth by region, North America and Western Europe were both up mid-single digits, and our growth in emerging markets was also up mid-single digits, with continued strong growth in South Asia and mid single-digit growth in China, which was partially offset by soft results in Eastern Europe. It is important to note that while we saw some timing related quarterly volatility in China during 2017, our full year growth in this important market was in the high-single digits. Our operating margin for this segment was strong, up 70 basis points on an adjusted basis to 12.2%, as the benefits from increased volume and productivity more than offset higher employee-related costs and a negative net impact from pricing and raw material costs. The sequential impact of raw material inflation was in line with our expectations for the quarter and while increases to-date has been gradual and relatively modest, we are expecting some further sequential inflation in the first quarter. We continue to address this through a combination of both product reengineering and pricing, and we have announced price increases in all regions over the past three months and we will take further actions as necessary. So shifting now to Retail Branding and Information Solutions, the RBIS team delivered another excellent quarter, as the team continues to execute extremely well on its business model transformation, enabling market share gains while driving significant margin expansion. Regional empowerment has moved decision-making closer to the market and improved local accountability, helping to speed and flexibility in the competitive advantages, and we continue to build a more efficient cost structure. RBIS sales were up 5% organically, driven by strength in both RFID and the base business, as well as the continued lift related to the 2018 World Cup. For the full year we do estimate that the World Cup related sales contributed roughly 80 basis points to organic growth in RBIS. Our volume growth has outpaced apparel unit imports into the U.S. and Europe for number of quarters now, giving us confidence that we are gaining share, with the performance athletic, premium and fast fashion segments leading the way sales. Sales of RFID products grew at the mid-teens rate for the quarter and we are targeting 15% to 20% plus compound annual growth for RFID over the long-term. Although, we do of course expect some volatility in the growth rate in any given quarter or year based on timing of customer implementations. And adjusted operating margin for this segment expanded by nearly two full points to 11.9%, driven by the benefits of productivity and higher volume, as well as the reduction in intangibles amortization. These benefits were partly offset by higher employee-related related costs and the net impact of pricing in raw material costs. And finally, turning to the Industrial and Healthcare Materials segment, with the benefit of Yongle and Finesse Medical acquisitions, sales rose 57% ex-currency. Our organic growth rose 6%, reflecting strength in both industrial tapes and Vancive medical products. Adjusted operating margin declined by roughly 2 points, due to the impact of acquisitions and other investment spending, as well as the near-term operational challenges that Mitch discussed. Over the coming years, we expect to see operating margin gradually expand to LGM’s level or better, achieving our long-term targets for this business by 2021. So turning now to our outlook for 2018, our anticipated adjusted earnings per share -- we anticipate adjusted earnings per share to be in the range of $5.70 to $5.95. We have outlined some of the key contribute factors to this guidance on slide 14 of our supplemental presentation materials. We estimate that organic sales growth will be approximate 4% for the year in line with the range we have experienced over the last few years. And we expect the impacts of -- impact of acquisitions on sales to be approximately 1.5% from closed deals. Our recent exchange rates, currency translation represents a roughly 2.5 point addition to reported sales growth and a pretax operating income tailwind of roughly $20 million. And we estimate the incremental pretax savings from restructuring actions will contribute between $30 million and $35 million in 2018, much of which represents a carryover benefit of actions initiated in 2017. And as I mentioned, we expected tax rate in the mid-20s and we have assumed 25% for purposes of our EPS guidance. And we anticipate spending roughly $250 million on fixed capital and IT projects. And note that while we have been increasing our pace of investment, our outlook for 2018 is consistent with the cumulative five-year spending target under our long-term capital allocation plan, which we communicated last March. And finally, we estimate average shares outstanding assuming dilution of 89 million shares to 90 million shares. So in summary, we are pleased with the strategic and financial progress we made against our long-term goals this year. And we are committed to delivering exceptional value to our strategies for long-term profitable growth and disciplined capital allocation. And with that, we will now open up the call for your questions.